P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?. (5th April 2022)

Record Type:: Journal Article
Title:: P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?. (5th April 2022)
Main Title:: P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?
Authors:: Popat, R
Badros, A
Kumar, S
Rodriguez-Otero, P
Cohen, A
Manier, S
Voorhees, P
Gay, F
Rifkin, R
Martin, T
Chari, A
Weisel, K
Farooq, A
Jeng, B
Chng, W
Lee, H
Berdeja, J
Jadhav, V
Tosolini, A
Eliason, L
Palumbo, A
Dimopoulos, M
Lonial, S
Trudel, S
Richardson, P
Terpos, E
Abstract:
Is Part Of:: HemaSphere. Volume 6(2022)Supplement 2
Journal:: HemaSphere
Issue:: Volume 6(2022)Supplement 2
Issue Display:: Volume 6, Issue 2 (2022)
Year:: 2022
Volume:: 6
Issue:: 2
Issue Sort Value:: 2022-0006-0002-0000
Page Start:: 18
Page End:: 18
Publication Date:: 2022-04-05
Subjects:: Hematology -- Periodicals
616.15005
Journal URLs:: https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/01.HS9.0000829624.40467.0d ↗
Languages:: English
ISSNs:: 2572-9241
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21663.xml